MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme

Glioblastoma is an aggressive tumor that occurs in both adult and pediatric patients and is known for its invasive quality and high rate of recurrence. Current therapies for glioblastoma result in high morbidity and dismal outcomes. The TAM subfamily of receptor tyrosine kinases includes Tyro3, Axl,...

Descripción completa

Detalles Bibliográficos
Autores principales: Knubel, Kristina H., Pernu, Ben M., Sufit, Alexandra, Nelson, Sarah, Pierce, Angela M., Keating, Amy K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012720/
https://www.ncbi.nlm.nih.gov/pubmed/24658326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012720/
https://www.ncbi.nlm.nih.gov/pubmed/24658326

Ejemplares similares